Thaci, Diamant, Alan Menter, Jashin J Wu, Dilek Arikan, Hartmut Kupper, Mareike Bereswill, and Wendell C Valdecantos. “Long-Term Safety and Effectiveness of Adalimumab for Moderat-to-Severe Psoriasis: Results from the Eight-Year Interim Analysis of the ESPIRIT Registry”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s22. Accessed December 2, 2020. https://jofskin.org/index.php/skin/article/view/79.